Science Corp., a developer of brain-computer interfaces and other medical equipment, today announced that it has raised $230 million in funding. The capital came from a consortium that included ...
Implantable device research from the BrainGate clinical trial enables communication through rapid typing for a patient with ...
China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...
China's drug regulator has approved the world's first commercial brain-computer interface (BCI) system, designed to restore ...
Parimal Deshpande on Adobe Express’ India strategy, AI-powered creation, regional language support and how design tools are ...
The firm is among a wave of Chinese startups building technologies that allow people to control computers or other electronic devices using only their minds ...
A brain-computer interface allowed two people who had lost the ability to move their limbs to type at speeds of up to 22 words per minute ...
As the tech industry shifts toward artificial intelligence agents and generative user interfaces, helping loved ones use ...
Implantable device research from the BrainGate clinical trial enables communication through rapid typing for a patient with ...
In a pivotal trial of Science’s Prima BCI, 84% of patients impacted by dry AMD were able to read again once fitted with the technology.
A source close to the company says the round assigns Science a post-money valuation of $1.25 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results